Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy.
- DOI
- 10.1016/j.ejca.2021.08.033
- Published
- 2021 Nov
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2021.08.033,
title = {Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy.},
author = {Clarke WA and Chatelut E and Fotoohi AK and Larson RA and Martin JH and Mathijssen RHJ and Salamone SJ},
year = {2021},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2021.08.033},
url = {https://doi.org/10.1016/j.ejca.2021.08.033}
}RIS
TY - JOUR TI - Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy. AU - Clarke WA AU - Chatelut E AU - Fotoohi AK AU - Larson RA AU - Martin JH AU - Mathijssen RHJ AU - Salamone SJ PY - 2021 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2021.08.033 UR - https://doi.org/10.1016/j.ejca.2021.08.033 ER -
APA
WA, C., E, C., AK, F., RA, L., JH, M., RHJ, M., & SJ, S. (2021). Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2021.08.033
Source records
- pubmed · retrieved 2026-09-24T21:18:50.209Z